Socio-behavioral dysfunction in disorders of hypothalamic-pituitary involvement: The potential role of disease-induced oxytocin and vasopressin signaling deficits

Lauren Clarke,Olena Zyga,Psalm L. Pineo-Cavanaugh,Michael Jeng,Nancy J. Fischbein,Sonia Partap,Laurence Katznelson,Karen J. Parker,Lauren Clarke,Olena Zyga,Michael Jeng,Sonia Partap,Laurence Katznelson
DOI: https://doi.org/10.1016/j.neubiorev.2022.104770
2022-09-01
Abstract:Disorders involving hypothalamic and pituitary (HPIT) structures—including craniopharyngioma, Langerhans cell histiocytosis, and intracranial germ cell tumors—can disrupt brain and endocrine function. An area of emerging clinical concern in patients with these disorders is the co-occurring socio-behavioral dysfunction that persists after standard hormone replacement therapy. Although the two neuropeptides most implicated in mammalian social functioning (oxytocin and arginine vasopressin) are of hypothalamic origin, little is known about how disease-induced damage to HPIT structures may disrupt neuropeptide signaling and, in turn, impact patients’ socio-behavioral functioning. Here we provide a clinical primer on disorders of HPIT involvement and a review of neuropeptide signaling and socio-behavioral functioning in relevant animal models and patient populations. This collective evidence suggests that neuropeptide signaling disruptions contribute to socio-behavioral deficits experienced by patients with disorders of HPIT involvement. A better understanding of the biological underpinnings of patients’ socio-behavioral symptoms is now needed to enable the development of the first targeted pharmacological strategies by which to manage patients’ socio-behavioral dysfunction.
behavioral sciences,neurosciences
What problem does this paper attempt to address?